nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—PTGS2—bile duct cancer	0.825	1	CbGaD
Diclofenac—CXCR1—lymph node—bile duct cancer	0.00414	0.0758	CbGeAlD
Diclofenac—ALB—gall bladder—bile duct cancer	0.00318	0.0583	CbGeAlD
Diclofenac—PLA2G2A—pancreas—bile duct cancer	0.00304	0.0557	CbGeAlD
Diclofenac—CXCL8—pancreas—bile duct cancer	0.00301	0.0552	CbGeAlD
Diclofenac—Bromfenac—PTGS2—bile duct cancer	0.00296	0.261	CrCbGaD
Diclofenac—Lumiracoxib—PTGS2—bile duct cancer	0.00252	0.222	CrCbGaD
Diclofenac—ASIC1—lymph node—bile duct cancer	0.00246	0.0451	CbGeAlD
Diclofenac—Nepafenac—PTGS2—bile duct cancer	0.00239	0.211	CrCbGaD
Diclofenac—TTR—pancreas—bile duct cancer	0.0023	0.0421	CbGeAlD
Diclofenac—ALOX5—pancreas—bile duct cancer	0.00208	0.0381	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—bile duct cancer	0.00196	0.173	CrCbGaD
Diclofenac—PLA2G2A—liver—bile duct cancer	0.00194	0.0354	CbGeAlD
Diclofenac—CXCL8—liver—bile duct cancer	0.00192	0.0351	CbGeAlD
Diclofenac—CYP2C18—liver—bile duct cancer	0.00177	0.0324	CbGeAlD
Diclofenac—PTGS2—gall bladder—bile duct cancer	0.00173	0.0317	CbGeAlD
Diclofenac—UGT2B7—liver—bile duct cancer	0.00163	0.0298	CbGeAlD
Diclofenac—SLC22A11—liver—bile duct cancer	0.00159	0.0291	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—bile duct cancer	0.00152	0.134	CrCbGaD
Diclofenac—PLA2G2A—lymph node—bile duct cancer	0.00149	0.0272	CbGeAlD
Diclofenac—CXCL8—lymph node—bile duct cancer	0.00147	0.0269	CbGeAlD
Diclofenac—TTR—liver—bile duct cancer	0.00146	0.0268	CbGeAlD
Diclofenac—ABCC4—pancreas—bile duct cancer	0.00142	0.026	CbGeAlD
Diclofenac—UGT1A1—liver—bile duct cancer	0.00139	0.0254	CbGeAlD
Diclofenac—ALOX5—liver—bile duct cancer	0.00133	0.0243	CbGeAlD
Diclofenac—SLCO1C1—lymph node—bile duct cancer	0.00125	0.023	CbGeAlD
Diclofenac—ALOX5—lymph node—bile duct cancer	0.00102	0.0186	CbGeAlD
Diclofenac—ALB—liver—bile duct cancer	0.000933	0.0171	CbGeAlD
Diclofenac—ABCC4—liver—bile duct cancer	0.000904	0.0165	CbGeAlD
Diclofenac—PTGS2—pancreas—bile duct cancer	0.000799	0.0146	CbGeAlD
Diclofenac—ABCC1—liver—bile duct cancer	0.00077	0.0141	CbGeAlD
Diclofenac—CYP2C19—liver—bile duct cancer	0.000752	0.0138	CbGeAlD
Diclofenac—ALB—lymph node—bile duct cancer	0.000716	0.0131	CbGeAlD
Diclofenac—ABCC4—lymph node—bile duct cancer	0.000693	0.0127	CbGeAlD
Diclofenac—CYP2C8—liver—bile duct cancer	0.000656	0.012	CbGeAlD
Diclofenac—CYP1A2—liver—bile duct cancer	0.000614	0.0112	CbGeAlD
Diclofenac—CYP1A1—liver—bile duct cancer	0.000606	0.0111	CbGeAlD
Diclofenac—ABCC1—lymph node—bile duct cancer	0.000591	0.0108	CbGeAlD
Diclofenac—CYP2B6—liver—bile duct cancer	0.000588	0.0108	CbGeAlD
Diclofenac—CYP2C9—liver—bile duct cancer	0.000583	0.0107	CbGeAlD
Diclofenac—CYP2E1—liver—bile duct cancer	0.000552	0.0101	CbGeAlD
Diclofenac—PTGS2—liver—bile duct cancer	0.000508	0.0093	CbGeAlD
Diclofenac—ABCB1—pancreas—bile duct cancer	0.000494	0.00905	CbGeAlD
Diclofenac—CYP1A1—lymph node—bile duct cancer	0.000464	0.0085	CbGeAlD
Diclofenac—CYP3A4—liver—bile duct cancer	0.000444	0.00813	CbGeAlD
Diclofenac—PTGS1—lymph node—bile duct cancer	0.000408	0.00746	CbGeAlD
Diclofenac—PTGS2—lymph node—bile duct cancer	0.00039	0.00713	CbGeAlD
Diclofenac—ABCB1—liver—bile duct cancer	0.000315	0.00576	CbGeAlD
Diclofenac—ABCB1—lymph node—bile duct cancer	0.000241	0.00441	CbGeAlD
Diclofenac—SCN4A—Developmental Biology—MMP9—bile duct cancer	0.000104	0.000953	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—bile duct cancer	0.000104	0.000952	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—SLC5A5—bile duct cancer	0.000104	0.000951	CbGpPWpGaD
Diclofenac—PTGS2—C-MYB transcription factor network—KRAS—bile duct cancer	0.000104	0.000949	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—MMP9—bile duct cancer	0.000103	0.000947	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—IDH1—bile duct cancer	0.000103	0.000944	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—bile duct cancer	0.000102	0.000939	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—HGF—bile duct cancer	0.000102	0.000938	CbGpPWpGaD
Diclofenac—PTGS1—Selenium Micronutrient Network—IL6—bile duct cancer	0.000102	0.000937	CbGpPWpGaD
Diclofenac—CXCL8—Cellular Senescence—IL6—bile duct cancer	0.000102	0.000933	CbGpPWpGaD
Diclofenac—ALB—Vitamin B12 Metabolism—IL6—bile duct cancer	0.000102	0.000931	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—bile duct cancer	0.0001	0.00092	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—bile duct cancer	0.0001	0.00092	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	9.89e-05	0.000907	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—GNAS—bile duct cancer	9.87e-05	0.000905	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	9.83e-05	0.000901	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—IDH2—bile duct cancer	9.72e-05	0.000892	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	9.72e-05	0.000891	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IDH1—bile duct cancer	9.63e-05	0.000883	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—bile duct cancer	9.48e-05	0.00087	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—HRAS—bile duct cancer	9.45e-05	0.000867	CbGpPWpGaD
Diclofenac—ALB—Platelet degranulation—TGFB1—bile duct cancer	9.4e-05	0.000862	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—IDH2—bile duct cancer	9.38e-05	0.00086	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—FAR2—bile duct cancer	9.36e-05	0.000858	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—NRAS—bile duct cancer	9.22e-05	0.000846	CbGpPWpGaD
Diclofenac—SLC22A6—Transmembrane transport of small molecules—GNAS—bile duct cancer	9.22e-05	0.000845	CbGpPWpGaD
Diclofenac—ABCC4—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	9.22e-05	0.000845	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—FAR2—bile duct cancer	9.13e-05	0.000838	CbGpPWpGaD
Diclofenac—SCN4A—Axon guidance—IL6—bile duct cancer	9.05e-05	0.00083	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—TP53—bile duct cancer	9.03e-05	0.000828	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—GNAS—bile duct cancer	8.96e-05	0.000822	CbGpPWpGaD
Diclofenac—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—bile duct cancer	8.96e-05	0.000821	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—NOS2—bile duct cancer	8.94e-05	0.000819	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—HRAS—bile duct cancer	8.9e-05	0.000816	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—HRAS—bile duct cancer	8.9e-05	0.000816	CbGpPWpGaD
Diclofenac—ABCC1—Transmembrane transport of small molecules—GNAS—bile duct cancer	8.83e-05	0.000809	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	8.83e-05	0.000809	CbGpPWpGaD
Diclofenac—PTGS2—C-MYB transcription factor network—HRAS—bile duct cancer	8.8e-05	0.000807	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—TGFB1—bile duct cancer	8.57e-05	0.000786	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—FAR2—bile duct cancer	8.53e-05	0.000783	CbGpPWpGaD
Diclofenac—KCNQ3—Developmental Biology—IL6—bile duct cancer	8.52e-05	0.000781	CbGpPWpGaD
Diclofenac—KCNQ2—Developmental Biology—IL6—bile duct cancer	8.52e-05	0.000781	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TGFB1—bile duct cancer	8.51e-05	0.000781	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—EGFR—bile duct cancer	8.4e-05	0.00077	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—TP53—bile duct cancer	8.4e-05	0.00077	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—IDH1—bile duct cancer	8.36e-05	0.000767	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—EGFR—bile duct cancer	8.35e-05	0.000766	CbGpPWpGaD
Diclofenac—ABCB1—Allograft Rejection—TGFB1—bile duct cancer	8.32e-05	0.000763	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—NRAS—bile duct cancer	8.3e-05	0.000761	CbGpPWpGaD
Diclofenac—ALB—Folate Metabolism—IL6—bile duct cancer	8.26e-05	0.000758	CbGpPWpGaD
Diclofenac—TTR—Disease—NOS2—bile duct cancer	8.23e-05	0.000755	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	8.19e-05	0.000751	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TGFBR2—bile duct cancer	8.18e-05	0.000751	CbGpPWpGaD
Diclofenac—PTGS2—Selenium Micronutrient Network—IL6—bile duct cancer	8.11e-05	0.000744	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—IDH1—bile duct cancer	8.06e-05	0.000739	CbGpPWpGaD
Diclofenac—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—bile duct cancer	8.06e-05	0.000739	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—GNAS—bile duct cancer	8.06e-05	0.000739	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	8.05e-05	0.000738	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—KRAS—bile duct cancer	7.94e-05	0.000728	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—IDH2—bile duct cancer	7.93e-05	0.000727	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—GNAS—bile duct cancer	7.9e-05	0.000724	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—SMAD4—bile duct cancer	7.75e-05	0.00071	CbGpPWpGaD
Diclofenac—CXCL8—Metabolism of proteins—MMP2—bile duct cancer	7.7e-05	0.000706	CbGpPWpGaD
Diclofenac—CXCL8—Cellular responses to stress—IL6—bile duct cancer	7.69e-05	0.000705	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—EGFR—bile duct cancer	7.56e-05	0.000693	CbGpPWpGaD
Diclofenac—PTGS2—Disease—RNF43—bile duct cancer	7.51e-05	0.000689	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—FAR2—bile duct cancer	7.29e-05	0.000669	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—KRAS—bile duct cancer	7.14e-05	0.000655	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—TP53—bile duct cancer	7.01e-05	0.000643	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—SLC5A5—bile duct cancer	6.98e-05	0.00064	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—bile duct cancer	6.88e-05	0.000631	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—IDH1—bile duct cancer	6.82e-05	0.000625	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—SLC5A5—bile duct cancer	6.79e-05	0.000623	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—HRAS—bile duct cancer	6.75e-05	0.000619	CbGpPWpGaD
Diclofenac—ALB—Selenium Micronutrient Network—IL6—bile duct cancer	6.56e-05	0.000602	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IDH1—bile duct cancer	6.46e-05	0.000593	CbGpPWpGaD
Diclofenac—SCN4A—Developmental Biology—IL6—bile duct cancer	6.46e-05	0.000592	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—ERBB2—bile duct cancer	6.44e-05	0.000591	CbGpPWpGaD
Diclofenac—PTGS2—Spinal Cord Injury—IL6—bile duct cancer	6.42e-05	0.000588	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—IDH2—bile duct cancer	6.29e-05	0.000577	CbGpPWpGaD
Diclofenac—TTR—Disease—ERBB2—bile duct cancer	6.19e-05	0.000568	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	6.17e-05	0.000566	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—HRAS—bile duct cancer	6.07e-05	0.000557	CbGpPWpGaD
Diclofenac—TTR—Disease—PTGS2—bile duct cancer	6.06e-05	0.000555	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—IDH2—bile duct cancer	6.05e-05	0.000555	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—IDH2—bile duct cancer	5.92e-05	0.000543	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—PTGS2—bile duct cancer	5.9e-05	0.000541	CbGpPWpGaD
Diclofenac—CXCR1—Signaling by GPCR—IL6—bile duct cancer	5.81e-05	0.000533	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—bile duct cancer	5.81e-05	0.000533	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	5.79e-05	0.000531	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	5.68e-05	0.000521	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—bile duct cancer	5.68e-05	0.000521	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—FAR2—bile duct cancer	5.63e-05	0.000516	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—IDH2—bile duct cancer	5.59e-05	0.000512	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—GNAS—bile duct cancer	5.54e-05	0.000508	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—MMP9—bile duct cancer	5.53e-05	0.000507	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—SLC5A5—bile duct cancer	5.52e-05	0.000506	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFBR2—bile duct cancer	5.49e-05	0.000503	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—GNAS—bile duct cancer	5.42e-05	0.000497	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—IDH1—bile duct cancer	5.41e-05	0.000496	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—SLC5A5—bile duct cancer	5.4e-05	0.000495	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	5.37e-05	0.000492	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—SLC5A5—bile duct cancer	5.32e-05	0.000488	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—GNAS—bile duct cancer	5.3e-05	0.000486	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—GNAS—bile duct cancer	5.28e-05	0.000484	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HGF—bile duct cancer	5.27e-05	0.000484	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—IDH1—bile duct cancer	5.2e-05	0.000477	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—SMAD4—bile duct cancer	5.2e-05	0.000477	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—IDH2—bile duct cancer	5.12e-05	0.00047	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFBR2—bile duct cancer	5.12e-05	0.000469	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—NRAS—bile duct cancer	5.11e-05	0.000469	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—IDH1—bile duct cancer	5.09e-05	0.000467	CbGpPWpGaD
Diclofenac—ALB—Metabolism—IDH2—bile duct cancer	5.09e-05	0.000467	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.99e-05	0.000457	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—NRAS—bile duct cancer	4.9e-05	0.00045	CbGpPWpGaD
Diclofenac—ABCC1—Disease—SMAD4—bile duct cancer	4.84e-05	0.000444	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—IDH1—bile duct cancer	4.8e-05	0.00044	CbGpPWpGaD
Diclofenac—ALB—Transmembrane transport of small molecules—GNAS—bile duct cancer	4.79e-05	0.000439	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	4.77e-05	0.000437	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TGFB1—bile duct cancer	4.75e-05	0.000436	CbGpPWpGaD
Diclofenac—TTR—Disease—NRAS—bile duct cancer	4.71e-05	0.000432	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—IDH2—bile duct cancer	4.57e-05	0.000419	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TGFB1—bile duct cancer	4.56e-05	0.000418	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—SLC5A5—bile duct cancer	4.5e-05	0.000412	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—EGFR—bile duct cancer	4.47e-05	0.00041	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—IDH2—bile duct cancer	4.46e-05	0.000409	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—IDH1—bile duct cancer	4.4e-05	0.000404	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—KRAS—bile duct cancer	4.4e-05	0.000403	CbGpPWpGaD
Diclofenac—ALB—Metabolism—IDH1—bile duct cancer	4.38e-05	0.000401	CbGpPWpGaD
Diclofenac—TTR—Disease—TGFB1—bile duct cancer	4.38e-05	0.000401	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—ERBB2—bile duct cancer	4.34e-05	0.000398	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PTGS2—bile duct cancer	4.33e-05	0.000397	CbGpPWpGaD
Diclofenac—TTR—Disease—EGFR—bile duct cancer	4.29e-05	0.000394	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GNAS—bile duct cancer	4.29e-05	0.000393	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—KRAS—bile duct cancer	4.22e-05	0.000387	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	4.21e-05	0.000386	CbGpPWpGaD
Diclofenac—ABCB1—Transmembrane transport of small molecules—GNAS—bile duct cancer	4.2e-05	0.000385	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—TGFB1—bile duct cancer	4.17e-05	0.000382	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—IDH2—bile duct cancer	4.17e-05	0.000382	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GNAS—bile duct cancer	4.13e-05	0.000379	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—bile duct cancer	4.11e-05	0.000377	CbGpPWpGaD
Diclofenac—TTR—Disease—KRAS—bile duct cancer	4.05e-05	0.000372	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NOS2—bile duct cancer	4.04e-05	0.000371	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—bile duct cancer	4.03e-05	0.000369	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—IDH1—bile duct cancer	3.93e-05	0.00036	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—bile duct cancer	3.91e-05	0.000359	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—IDH1—bile duct cancer	3.84e-05	0.000352	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—bile duct cancer	3.8e-05	0.000349	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—bile duct cancer	3.75e-05	0.000344	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—NRAS—bile duct cancer	3.75e-05	0.000343	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—HRAS—bile duct cancer	3.74e-05	0.000343	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MMP9—bile duct cancer	3.72e-05	0.000341	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NOS2—bile duct cancer	3.61e-05	0.000331	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HRAS—bile duct cancer	3.59e-05	0.000329	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—IDH1—bile duct cancer	3.58e-05	0.000329	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—SLC5A5—bile duct cancer	3.57e-05	0.000327	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—IDH2—bile duct cancer	3.56e-05	0.000327	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GNAS—bile duct cancer	3.49e-05	0.00032	CbGpPWpGaD
Diclofenac—TTR—Disease—HRAS—bile duct cancer	3.45e-05	0.000316	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFBR2—bile duct cancer	3.43e-05	0.000315	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—IL6—bile duct cancer	3.43e-05	0.000315	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—SLC5A5—bile duct cancer	3.43e-05	0.000315	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—EGFR—bile duct cancer	3.41e-05	0.000313	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—bile duct cancer	3.38e-05	0.00031	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—SLC5A5—bile duct cancer	3.36e-05	0.000308	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—NRAS—bile duct cancer	3.3e-05	0.000303	CbGpPWpGaD
Diclofenac—TTR—Disease—IL6—bile duct cancer	3.3e-05	0.000302	CbGpPWpGaD
Diclofenac—PTGS2—Disease—SMAD4—bile duct cancer	3.25e-05	0.000298	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—KRAS—bile duct cancer	3.22e-05	0.000296	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—SLC5A5—bile duct cancer	3.17e-05	0.000291	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TGFB1—bile duct cancer	3.07e-05	0.000281	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—IDH1—bile duct cancer	3.06e-05	0.000281	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EGFR—bile duct cancer	3.01e-05	0.000276	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.97e-05	0.000272	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTGS2—bile duct cancer	2.91e-05	0.000267	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—ERBB2—bile duct cancer	2.91e-05	0.000267	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—SLC5A5—bile duct cancer	2.91e-05	0.000266	CbGpPWpGaD
Diclofenac—ALB—Metabolism—SLC5A5—bile duct cancer	2.89e-05	0.000265	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—KRAS—bile duct cancer	2.84e-05	0.00026	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTGS2—bile duct cancer	2.83e-05	0.00026	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GNAS—bile duct cancer	2.77e-05	0.000254	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—IDH2—bile duct cancer	2.75e-05	0.000252	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HRAS—bile duct cancer	2.74e-05	0.000251	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.72e-05	0.00025	CbGpPWpGaD
Diclofenac—ABCC1—Disease—ERBB2—bile duct cancer	2.71e-05	0.000249	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.71e-05	0.000248	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GNAS—bile duct cancer	2.67e-05	0.000244	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTGS2—bile duct cancer	2.65e-05	0.000243	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—IL6—bile duct cancer	2.62e-05	0.000241	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GNAS—bile duct cancer	2.61e-05	0.000239	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—SLC5A5—bile duct cancer	2.59e-05	0.000238	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—SLC5A5—bile duct cancer	2.53e-05	0.000232	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—bile duct cancer	2.52e-05	0.000231	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MMP9—bile duct cancer	2.49e-05	0.000229	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GNAS—bile duct cancer	2.46e-05	0.000226	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.43e-05	0.000223	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOS2—bile duct cancer	2.42e-05	0.000222	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—bile duct cancer	2.41e-05	0.000221	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC5A5—bile duct cancer	2.36e-05	0.000217	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—IDH1—bile duct cancer	2.36e-05	0.000217	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NRAS—bile duct cancer	2.31e-05	0.000212	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—bile duct cancer	2.31e-05	0.000212	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—bile duct cancer	2.3e-05	0.000211	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GNAS—bile duct cancer	2.26e-05	0.000207	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GNAS—bile duct cancer	2.24e-05	0.000206	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—bile duct cancer	2.22e-05	0.000204	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	2.22e-05	0.000203	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NRAS—bile duct cancer	2.21e-05	0.000203	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TGFB1—bile duct cancer	2.15e-05	0.000197	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NRAS—bile duct cancer	2.06e-05	0.000189	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TGFB1—bile duct cancer	2.06e-05	0.000189	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC5A5—bile duct cancer	2.02e-05	0.000185	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—bile duct cancer	2.02e-05	0.000185	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GNAS—bile duct cancer	2.01e-05	0.000185	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—bile duct cancer	1.99e-05	0.000183	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GNAS—bile duct cancer	1.97e-05	0.00018	CbGpPWpGaD
Diclofenac—ABCC1—Disease—TGFB1—bile duct cancer	1.92e-05	0.000176	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—bile duct cancer	1.9e-05	0.000175	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—bile duct cancer	1.89e-05	0.000174	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—bile duct cancer	1.88e-05	0.000172	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—bile duct cancer	1.88e-05	0.000172	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GNAS—bile duct cancer	1.84e-05	0.000168	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—bile duct cancer	1.82e-05	0.000167	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—bile duct cancer	1.78e-05	0.000163	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—bile duct cancer	1.77e-05	0.000162	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—bile duct cancer	1.69e-05	0.000155	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—bile duct cancer	1.69e-05	0.000155	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—bile duct cancer	1.62e-05	0.000148	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GNAS—bile duct cancer	1.57e-05	0.000144	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC5A5—bile duct cancer	1.56e-05	0.000143	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—bile duct cancer	1.55e-05	0.000142	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—bile duct cancer	1.51e-05	0.000138	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—bile duct cancer	1.44e-05	0.000132	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—bile duct cancer	1.43e-05	0.000131	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—bile duct cancer	1.4e-05	0.000129	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—bile duct cancer	1.38e-05	0.000127	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—bile duct cancer	1.32e-05	0.000121	CbGpPWpGaD
Diclofenac—PTGS2—Disease—TGFB1—bile duct cancer	1.29e-05	0.000118	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—bile duct cancer	1.26e-05	0.000116	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—bile duct cancer	1.21e-05	0.000111	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GNAS—bile duct cancer	1.21e-05	0.000111	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—bile duct cancer	1.21e-05	0.000111	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—bile duct cancer	1.19e-05	0.000109	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—bile duct cancer	1.08e-05	9.92e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—bile duct cancer	1.06e-05	9.68e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—bile duct cancer	1.01e-05	9.29e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—bile duct cancer	9.87e-06	9.05e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—bile duct cancer	9.69e-06	8.89e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—bile duct cancer	8.43e-06	7.73e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—bile duct cancer	6.51e-06	5.97e-05	CbGpPWpGaD
